The FDA has issued a draft guidance to simplify the procedure of developing drugs for rare pediatric disorders.
Low-income pregnant women in Texas were less likely to deliver babies early after the state’s Medicaid insurance program stopped paying for preterm elective births.
An inhalation solution used in children with asthma for the relief of bronchospasm has be recalled by the drug producer.
Data shows that transfers from the emergency department to another facility occur more frequently among pediatric patients without insurance or with Medicaid.
An injection indicated for the nutritional support of infants and young children is being recalled due to customer reports of solution discoloration.